Literature DB >> 25356172

GSTP1 arrests bladder cancer T24 cells in G0/G1 phase and up-regulates p21 expression.

Li Gao1, You-Qiang Fang2, Tian-Yu Zhang1, Bo Ge1, Bin Xu1, Jie-Fu Huang1, Zhen-Feng Zhang3, Ning Tan4.   

Abstract

OBJECTIVE: GSTP1 over-expression was introduced into human bladder cancer T24 cells via the lentivirus system. The influence of GSTP1 on the proliferation and cell cycle of T24 cells as well as the potential mechanisms was investigated.
METHODS: The lentiviral vector GSTP1-pWPXL was constructed and transfected into T24 cells in the presence of Lipofectamine 2000. CCK8 assay and colony formation test were performed to explore the impact of GSTP1 on the proliferation of T24 cells. Ollowing PI staining, flow cytometry was done to detect the proportion of T24 cells in different phases. Western blot assay was conducted to detect the protein p21 expression.
RESULTS: When compared with control group, T24 cells with GSTP1 over-expression showed significant reduction in cell proliferation (P < 0.01) and they were arrested in G0/G1 phase. Western blot assay indicated that the p21 protein expression in T24 cells with GSTP1 over-expression was significantly higher than that in control group.
CONCLUSION: GSTP1 may inhibit the proliferation of T24 cells and arrest these cells in G0/G1 phase, which may be ascribed to the up-regulated expression of p21.

Entities:  

Keywords:  Bladder cancer; GSTP1; cell cycle; cell proliferation; p2

Year:  2014        PMID: 25356172      PMCID: PMC4211822     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  7 in total

Review 1.  ATP-noncompetitive CDK inhibitors for cancer therapy: an overview.

Authors:  Agnese Anna Abate; Francesca Pentimalli; Luca Esposito; Antonio Giordano
Journal:  Expert Opin Investig Drugs       Date:  2013-06-04       Impact factor: 6.206

Review 2.  [Involvement of cyclin-dependent kinase CDK1/CDC28 in regulation of cell cycle].

Authors:  N A Koltovaya
Journal:  Genetika       Date:  2013-07

Review 3.  Cancers of the bladder.

Authors:  N Sengupta; Emad Siddiqui; Faiz H Mumtaz
Journal:  J R Soc Promot Health       Date:  2004-09

Review 4.  p21 in cancer: intricate networks and multiple activities.

Authors:  Tarek Abbas; Anindya Dutta
Journal:  Nat Rev Cancer       Date:  2009-06       Impact factor: 60.716

5.  Dual effects of glutathione-S-transferase pi on As2O3 action in prostate cancer cells: enhancement of growth inhibition and inhibition of apoptosis.

Authors:  Min Lu; Lijuan Xia; David Luo; Samuel Waxman; Yongkui Jing
Journal:  Oncogene       Date:  2004-05-13       Impact factor: 9.867

Review 6.  Multiple roles of the cell cycle inhibitor p21(CDKN1A) in the DNA damage response.

Authors:  Ornella Cazzalini; A Ivana Scovassi; Monica Savio; Lucia A Stivala; Ennio Prosperi
Journal:  Mutat Res       Date:  2010-01-22       Impact factor: 2.433

7.  Drug resistance features and S-phase fraction as possible determinants for drug response in a panel of human ovarian cancer xenografts.

Authors:  G M Kolfschoten; T M Hulscher; H M Pinedo; E Boven
Journal:  Br J Cancer       Date:  2000-10       Impact factor: 7.640

  7 in total
  4 in total

1.  High GSTP1 inhibits cell proliferation by reducing Akt phosphorylation and is associated with a better prognosis in hepatocellular carcinoma.

Authors:  Xiaojia Liu; Ning Tan; Hongtao Liao; Guangdong Pan; Qing Xu; Rong Zhu; Liping Zou; Songqing He; Hongguang Zhu
Journal:  Oncotarget       Date:  2017-12-19

2.  FBX8 degrades GSTP1 through ubiquitination to suppress colorectal cancer progression.

Authors:  Wang FeiFei; Xu HongHai; Yan YongRong; Wu PingXiang; Wu JianHua; Zhu XiaoHui; Li JiaoYing; Sun JingBo; Zhou Kun; Ren XiaoLi; Qi Lu; Lan XiaoLiang; Cheng ZhiQiang; Tang Na; Liao WenTing; Ding YanQing; Liang Li
Journal:  Cell Death Dis       Date:  2019-04-25       Impact factor: 8.469

Review 3.  Roles of SPARC in urothelial carcinogenesis, progression and metastasis.

Authors:  Neveen Said
Journal:  Oncotarget       Date:  2016-10-11

4.  Environment and bladder cancer: molecular analysis by interaction networks.

Authors:  Andrea Polo; Anna Crispo; Pellegrino Cerino; Luca Falzone; Saverio Candido; Aldo Giudice; Giuseppina De Petro; Gennaro Ciliberto; Maurizio Montella; Alfredo Budillon; Susan Costantini
Journal:  Oncotarget       Date:  2017-05-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.